metformin has been researched along with Carbohydrate Inducible Hyperlipemia in 2 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miklankova, D | 1 |
| Markova, I | 1 |
| Hüttl, M | 1 |
| Zapletalova, I | 1 |
| Poruba, M | 1 |
| Malinska, H | 1 |
| Franceschini, G | 1 |
| Sirtori, CR | 1 |
| Capurso, A | 1 |
| Weisgraber, KH | 1 |
| Mahley, RW | 1 |
2 other studies available for metformin and Carbohydrate Inducible Hyperlipemia
| Article | Year |
|---|---|
Metformin Affects Cardiac Arachidonic Acid Metabolism and Cardiac Lipid Metabolite Storage in a Prediabetic Rat Model.
Topics: Animals; Arachidonic Acid; Basal Metabolism; Biomarkers; Cardiotonic Agents; Disease Models, Animal; | 2021 |
A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family.
Topics: Adolescent; Adult; Child; Cholesterol; Dietary Fats; Electrophoresis, Polyacrylamide Gel; Female; Hu | 1980 |